Atrial fibrillation in hypertrophic cardiomyopathy-A contemporary mini-review

被引:10
|
作者
Dragasis, Stylianos [1 ]
Vlachos, Konstantinos [1 ]
Kariki, Ourania [1 ]
Koskina, Stavroula [1 ]
Zygouri, Andromahi [1 ]
Patsiotis, Ilias G. [2 ]
Anastasakis, Aris [1 ]
Athanasopoulos, George [1 ]
Ritsatos, Konstantinos [1 ]
Letsas, Konstantinos [1 ]
Efremidis, Michael [1 ]
机构
[1] Onassis Cardiac Surg Canter, Leof Andrea Siggrou 356, Athens 17674, Greece
[2] Gen State Hosp Nikaia St Panteleimon, Nikaia, Greece
关键词
Atrial fibrillation; Hypertrophic cardiomyopathy; Arterial thromboembolism; CLINICAL PROFILE; SURGICAL ABLATION; OUTCOMES; IMPACT; PREDICTORS; MANAGEMENT; DIAGNOSIS; FIBROSIS; CATHETER; STROKE;
D O I
10.1016/j.hjc.2022.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic cardiomyopathy (HCM) represents the most common genetically inherited cardiovascular disorder and a leading cause of heart failure and sudden cardiac death. Atrial fibrillation (AF) is the most common arrhythmia encountered in HCM patients, primarily due to the process of left atrium dilatation and remodeling. Its presence typically leads to progressive functional decline, increased frequency of heart failure hospitalizations, and increased thromboembolic risk. In this mini-review, we summarize the contemporary data on AF pathophysiology, risk factors, and management in HCM patients suffering from AF.(c) 2022 Hellenic Society of Cardiology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [21] Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a systematic review and meta-analysis
    Ye, Tiffany T. S.
    Siah, Qi Zhuang
    Tan, Benjamin Y. Q.
    Ho, Jamie S. Y.
    Syn, Nicholas L. X.
    Teo, Yao Hao
    Teo, Yao Neng
    Yip, James W.
    Yeo, Tiong-Cheng
    Lin, Weiqin
    Wong, Raymond C. C.
    Chai, Ping
    Chan, Bernard
    Sharma, Vijay Kumar
    Yeo, Leonard L. L.
    Sia, Ching-Hui
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (01) : 83 - 91
  • [22] Predicting New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy: A Review
    Dicorato, Marco Maria
    Basile, Paolo
    Naccarati, Maria Ludovica
    Carella, Maria Cristina
    Dentamaro, Ilaria
    Falagario, Alessio
    Cicco, Sebastiano
    Forleo, Cinzia
    Guaricci, Andrea Igoren
    Ciccone, Marco Matteo
    Santobuono, Vincenzo Ezio
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
  • [23] Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation
    Aglan, Amro
    Fath, Ayman R.
    Maron, Barry J.
    Maron, Martin S.
    Prasad, Anand
    Almomani, Ahmed
    Hammadah, Muhammad
    Reynolds, Matthew R.
    Rowin, Ethan J.
    HEART RHYTHM, 2024, 21 (09) : 1677 - 1683
  • [24] Clinical and Genetic Risk Factors Predict Atrial Fibrillation on the Basis of Hypertrophic Cardiomyopathy
    Lee, Young Shin
    Yang, Pil-Sung
    Jang, Eunsun
    Kim, Daehoon
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Sung, Jung-Hoon
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Kim, Jin-Bae
    Joung, Boyoung
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (06):
  • [25] Risk factors for atrial fibrillation in hypertrophic cardiomyopathy
    Philipson, Daniel J.
    Rader, Florian
    Siegel, Robert J.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (06) : 658 - 665
  • [26] Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy
    Kubo, Toru
    Baba, Yuichi
    Ochi, Yuri
    Hirota, Takayoshi
    Yamasaki, Naohito
    Kawai, Kazuya
    Yamamoto, Katsuhito
    Kondo, Fumiaki
    Bando, Kanji
    Yamada, Eisuke
    Furuno, Takashi
    Yabe, Toshikazu
    Doi, Yoshinori L.
    Kitaoka, Hiroaki
    ESC HEART FAILURE, 2021, 8 (06): : 5022 - 5030
  • [27] Clinical and pathophysiologic determinants of catheter ablation outcome in hypertrophic cardiomyopathy with atrial fibrillation
    Lee, Jae-Hyuk
    Cho, Iksung
    Choi, Sung Hwa
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Joung, Boyoung
    Lee, Moon-Hyoung
    Hong, Geu-Ru
    Hwang, Chun
    Pak, Hui-Nam
    JOURNAL OF ARRHYTHMIA, 2024, 40 (03) : 479 - 488
  • [28] Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
    Dominguez, Fernando
    Climent, Vicente
    Zorio, Esther
    Ripoll-Vera, Tomas
    Salazar-Mendiguchia, Joel
    Manuel Garcia-Pinilla, Jose
    Angel Urbano-Moral, Jose
    Fernandez-Fernandez, Xusto
    Lopez-Cuenca, David
    Ajo-Ferrer, Raquel
    Sanz-Sanchez, Jorge
    Gomez-Perez, Yolanda
    Lopez-Garrido, Miguel A.
    Barriales-Villa, Roberto
    Ramon Gimeno, Juan
    Garcia-Pavia, Pablo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 232 - 238
  • [29] Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review
    Patricia Alphonse
    Sohaib Virk
    Jhonna Collins
    Timothy Campbell
    Stuart P. Thomas
    Christopher Semsarian
    Saurabh Kumar
    Clinical Research in Cardiology, 2021, 110 : 544 - 554
  • [30] Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study
    Choi, You-Jung
    Choi, Eue-Keun
    Han, Kyung-Do
    Jung, Jin-Hyung
    Park, Jiesuck
    Lee, Euijae
    Choe, Wonseok
    Lee, So-Ryoung
    Cha, Myung-Jin
    Lim, Woo-Hyun
    Oh, Seil
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 130 - 135